GSA Capital Partners’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$31K Sell
2022
Q2
$178K Buy
2022
Q1
$99K Buy
2021
Q4
$26K Buy
2019
Q2
Sell
2019
Q1
$123K Sell
2018
Q4
$85K Buy
2018
Q3
Sell
2018
Q2
$170K Hold
2018
Q1
$197K Buy
2014
Q3
Sell
2014
Q2
$32K Buy